JEREMY FICKEN: Open Payments
NPI 1699164202 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,389 in 84 payments from 16 companies in 2025. Trend: 2023 $1,504 · 2024 $1,688 · 2025 $1,389
Food & beverage: $1,389
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $250 |
| Astellas Pharma US Inc | 8 | $205 |
| Novo Nordisk Inc | 17 | $170 |
| Lilly USA, LLC | 12 | $127 |
| Dexcom, Inc. | 5 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Merck Sharp & Dohme LLC | 4 | $75 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $62 |
| ABBVIE INC. | 2 | $56 |
Products named: Veozah, ELIQUIS, Dexcom G6 Transmitter, Ozempic, MOUNJARO, REXULTI, Wegovy, PREVNAR 13.
Industry payments across AZ — which companies pay providers there.
